Novel inhibitors of enkephalin-degrading enzymes. II: N5'-substituted-4-thioxohydantoic acids as aminopeptidase inhibitors

Some 2-substituted-(2'-aminophenyl)-4-thioxohydantoic acids (o-amino PTC-amino acids) have antinociceptive activity when administered (icv) alone (IC50 = 0.04-0.87 microM/animal) and show a striking prolongation of the antinociceptive action of (D-Ala-2 D-Leu5)-enkephalin (DADL) in combination. The effects are thought to be mediated via opioid receptors since they are naloxone-reversible. Although inhibitors of the enkephalin degrading puromycin-insensitive, bestatin-sensitive aminopeptidase (possibly aminopeptidase M) their action is weak (IC50 = 32 microM leucine, 536 microM, glycine) and they might be considered to have a direct antinociceptive effect on opioid receptors. The titled compounds constitute novel 'lead' compounds for the development of potent aminopeptidase M inhibitors.

The results of radiation therapy in advanced carcinoma of the lung in the Beijing region of China

From 1958 to 1973, 682 patients with lung cancer were treated by radiation therapy in the Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China. The clinical presentation, sex, age, histology and stage and palliative effects of radiation therapy were reported. The 1-, 3- and 5-year survival rates were 40.62, 8.94 and 3.81%, respectively. The prognostic factors such as staging, histology, combination with chemotherapy and response of tumours are discussed. The causes of failure are also analysed. It is suggested that improving the local control rate of squamous cell carcinoma would increase the survival rate.